![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 6, 4476-4484, February 9, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Amyloid (A
The Protease Inhibitor, MG132, Blocks Maturation of the
Amyloid Precursor Protein Swedish Mutant Preventing Cleavage by
-Secretase*
§,
Institute of Gerontology and Department of
Biological Chemistry, University of Michigan, Ann Arbor, Michigan 48109 and the ¶ Department of Neurology, University of Michigan Medical
Center, Ann Arbor, Michigan 48109 and Veterans Affairs Medical Center
Geriatric Research, Education, and Clinical Center,
Ann Arbor, Michigan 48105
) peptides found aggregated into
plaques in Alzheimer's disease are derived from the sequential
cleavage of the amyloid precursor protein (APP) first by
- and then
by
-secretases. Peptide aldehydes, which inhibit cysteine proteases
and proteasomes, reportedly block A
peptide secretion by interfering
with
-secretase cleavage. Using a novel, specific, and sensitive
enzyme-linked immunosorbent assay for the
-secretase-cleaved
fragment of the Swedish mutant of APP (APPSw), we determined that the
peptide aldehyde, MG132, prevented
-secretase cleavage. This block
in
-secretase cleavage was not observed with
clasto-lactacystin
-lactone and thus, cannot be
attributed to proteasomal inhibition. MG132 inhibition of
-secretase
cleavage was compared with the serine protease inhibitor,
4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride (AEBSF). AEBSF
inhibition of
-secretase cleavage was immediate and did not affect
-secretase cleavage. With MG132, inhibition was delayed and it
decreased secretion of
-cleaved APPSw as well. Furthermore, MG132
treatment impaired maturation of full-length APPSw. Both inhibited
intracellular formation of the
-cleaved product. These results
suggest that peptide aldehydes such as MG132 have multiple effects on
the maturation and processing of APP. We conclude that the
MG132-induced decrease in
-secretase cleavage of APPSw is due to a
block in maturation. This is sufficient to explain the previously
reported peptide aldehyde-induced decrease in A
peptide secretion.
*
This work was supported in part by a Michigan Alzheimer's
Disease Research Center pilot grant (to J. R. G.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Inst. of
Gerontology and Dept. of Biological Chemistry, University of Michigan, 300 N. Ingalls, Rm. 973, Ann Arbor, MI 48109. Tel.: 734-764-3250; E-mail: jrgaut@umich.edu.
This article has been cited by other articles:
![]() |
C. U. Hubbers, C. S. Clemen, K. Kesper, A. Boddrich, A. Hofmann, O. Kamarainen, K. Tolksdorf, M. Stumpf, J. Reichelt, U. Roth, et al. Pathological consequences of VCP mutations on human striated muscle Brain, February 1, 2007; 130(2): 381 - 393. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Das and V. Boggaram Proteasome dysfunction inhibits surfactant protein gene expression in lung epithelial cells: mechanism of inhibition of SP-B gene expression Am J Physiol Lung Cell Mol Physiol, January 1, 2007; 292(1): L74 - L84. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Huang, D. C. Muddiman, and D. J. Tindall Androgens Negatively Regulate Forkhead Transcription Factor FKHR (FOXO1) through a Proteolytic Mechanism in Prostate Cancer Cells J. Biol. Chem., April 2, 2004; 279(14): 13866 - 13877. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Lanz, C. S. Himes, G. Pallante, L. Adams, S. Yamazaki, B. Amore, and K. M. Merchant The {gamma}-Secretase Inhibitor N-[N-(3,5-Difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl Ester Reduces A{beta} Levels in Vivo in Plasma and Cerebrospinal Fluid in Young (Plaque-Free) and Aged (Plaque-Bearing) Tg2576 Mice J. Pharmacol. Exp. Ther., June 1, 2003; 305(3): 864 - 871. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lammich, M. Okochi, M. Takeda, C. Kaether, A. Capell, A.-K. Zimmer, D. Edbauer, J. Walter, H. Steiner, and C. Haass Presenilin-dependent Intramembrane Proteolysis of CD44 Leads to the Liberation of Its Intracellular Domain and the Secretion of an Abeta -like Peptide J. Biol. Chem., November 15, 2002; 277(47): 44754 - 44759. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Corcoran, Y. Lu, R. S. Turner, and S. Maren Overexpression of hAPPswe Impairs Rewarded Alternation and Contextual Fear Conditioning in a Transgenic Mouse Model of Alzheimer's Disease Learn. Mem., September 1, 2002; 9(5): 243 - 252. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Ho, V. Marinescu, M. L. Steinhilb, J. R. Gaut, R. S. Turner, and E. L. Stuenkel Synergistic Effects of Munc18a and X11 Proteins on Amyloid Precursor Protein Metabolism J. Biol. Chem., July 19, 2002; 277(30): 27021 - 27028. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-T. Gau, M. L. Steinhilb, T.-C. Kao, C. J. D'Amato, J. R. Gaut, K. A. Frey, and R. S. Turner Stable {beta}-Secretase Activity and Presynaptic Cholinergic Markers During Progressive Central Nervous System Amyloidogenesis in Tg2576 Mice Am. J. Pathol., February 1, 2002; 160(2): 731 - 738. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Robert, J. L. Zugaza, R. Fischmeister, A. M. Gardier, and F. Lezoualc'h The Human Serotonin 5-HT4 Receptor Regulates Secretion of Non-amyloidogenic Precursor Protein J. Biol. Chem., November 21, 2001; 276(48): 44881 - 44888. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |